Myriad RBM Annual Revenue, Number of Employees, Growth and Funding

Claim your profile

Overview

Location:
Austin, TX USA
Total Funding:N/A
Industry:Biotech
Founded:2002
Lead Investor(s):N/A
Press
Claim your profile

State Ranking

Estimated Revenue & Financials

  • Myriad RBM's estimated annual revenue is currently $16.7M per year.
  • Myriad RBM's estimated revenue per employee is $144,310

Employee Data

  • Myriad RBM has 116 Employees.
  • Myriad RBM grew their employee count by 7% last year.
  • Myriad RBM currently has N/A job openings.

Executive Contacts

NameTitle
Dennis DentonVP, IS & Technology
Samuel LaBrieSVP Corporate Development
James MapesSVP/Chief Scientific Officer
Ralph McDadePresident
Janet YangDirector, Business Development--Western Region
Don BeamishVP Commercial Development
Kelley NitkaSr Director of Lab Operations
Raymond CaseyDirector of Manufacturing Myriad RBM
Margaret SandefurVP Quality Assurance/ Regulatory Compliance
karri ballardSenior Director, Clinical Research

Myriad RBM, Inc. is the world's leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its Multi-Analyte Profiling (MAP) platform. This platform provides pre-clinical and clinical researchers with reproducible and quantitative data for a few or hundreds of proteins in a cost-effective manner. All services are performed in our CLIA certified laboratory. As a guide to drug development researchers, Myriad RBM also offers strategic biomarker services that include companion diagnostics, custom assay development, co-sponsored research programs, and innovative cell culture products. Myriad RBM's biomarker testing laboratory is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN).

keywords:N/A

116

Number of Employees

$16.7M

Revenue (est)

N/A

Current Jobs

7%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Bellicum Pharma...
$1.1M148-11%N/A
G-CON Manufactu...
$8.8M6133%N/A
BioNews Service...
$8.7M6011%N/A
Luminex Corpora...
$158.4M109410%N/A
Family Tree DNA
$5.7M4018%N/A
XBiotech USA
$10.9M7512%N/A
Celling Bioscie...
$9M62-2%N/A
Gradalis
$6.2M4343%N/A
Myriad RBM
$16.7M1167%N/A
Selleck Chemica...
$22M1528%N/A

Myriad RBM News

14-Sep-19 - Global Neurological Biomarkers Market 2019 – Quanterix ...

Quanterix, Myriad RBM, QIAGEN, ADx NeuroSciences, Merck, Euroimmun, Thermo Fisher, BioCrypton, ACOBIOM, Banyan Biomarkers, Olink ...

13-Sep-19 - Genetic Testing Market Benefits, Forthcoming Developments ...

... Inc.), Myriad Genetics, Inc. (Myriad RBM, Inc.), Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd., Eurofins Scientific, Illumina, Inc., ...

12-Sep-19 - Global Neurological Biomarkers Market 2019 Major ...

Key players operating world wide: Thermo Fisher, Merck, Bio-Rad Laboratories, Roche, QIAGEN, Athena Diagnostics, Myriad RBM, Cisbio ...